None ...

Among patients with low-grade, intermediate-risk NMIBC, UGN-102 generated robust, durable responses in an analysis of the ...

Pembrolizumab provided clinical benefit in previously treated advanced clear cell gynaecological cancer (CCGC). A single-arm ...

Oncology studies present unique challenges when it comes to participant treatment, resupply, and study management.

Retrograde Mars in Cancer has been taking you on a deep dive into your hidden emotions and on February 18, 2025, we ...

In a "tiny house lab" - a dedicated residential lab space for indoor air quality research - Jung and Boor are using the latest industry-developed air quality instruments to track how household ...

Racial and ethnic disparities were identified in immunotherapy receipt for Black patients with metastatic triple-negative ...

In gifts delivered, donations made and services pledged, Central Texans came through for the Statesman's largest charity ...

Cancer therapy has always struggled with targeting tumor cells effectively while minimizing damage to healthy tissue.

The University of Kentucky (Lexington, Ky.) and HGA are planning a new UK cancer and advanced ambulatory center in Lexington.

One of Monte Rosa's main differentiating factors is its proprietary QuEEN platform to design new molecular glue degraders.

The approach requires balance, however. There is the risk of increased AEs, as well as financial toxicity. Friedlander shared ...